New England Journal of Medicine · 2015 · 1.1K citations · 30 references
PharmacyTranslational SciencesClinical MedicinePrecision MedicineTranslational MedicinePersonalized Treatment PlanningPersonalized Medicine BiomarkersPersonalized Medicine ImplementationPharmaceutical MarketsPrecision Medicine ApplicationsPrecision Medicine EvaluationPrecision Medicine InnovationPrecision Medicine PolicyPrecision Therapeutics
This article considers the growing recognition of precision medicine by clinicians, patients, the pharmaceutical industry, and policymakers and summarizes how this rapidly accelerating field will leave a major imprint on the practice of medicine.
30
A New Initiative on Precision Medicine
Francis S. Collins, Harold Varmus · New England Journal of Medicine · 2015 · 5.2K citations · Full text
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations
Medicine, Oncology, Pharmacology +14
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty, Igor Puzanov, Kevin B. Kim et al. · New England Journal of Medicine · 2010 · 3.5K citations
Medicine, Oncology, Pharmacology +17